Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ferrosoferric Oxide | 5 | 2019 | 360 | 1.710 |
Why?
|
Portal Vein | 3 | 2024 | 437 | 1.050 |
Why?
|
Magnetic Resonance Imaging | 24 | 2024 | 35421 | 1.030 |
Why?
|
Tomography, X-Ray Computed | 27 | 2024 | 20129 | 0.940 |
Why?
|
Vascular Diseases | 4 | 2020 | 1161 | 0.900 |
Why?
|
Venous Thrombosis | 3 | 2020 | 1239 | 0.830 |
Why?
|
Coronary Angiography | 10 | 2023 | 4577 | 0.810 |
Why?
|
Aorta | 5 | 2024 | 2061 | 0.740 |
Why?
|
Magnetic Resonance Angiography | 4 | 2023 | 1442 | 0.730 |
Why?
|
Contrast Media | 15 | 2019 | 5300 | 0.720 |
Why?
|
Vena Cava, Inferior | 2 | 2020 | 440 | 0.690 |
Why?
|
Diagnostic Imaging | 8 | 2024 | 3507 | 0.680 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 173 | 0.670 |
Why?
|
Pelvic Neoplasms | 2 | 2020 | 254 | 0.660 |
Why?
|
Abdominal Injuries | 1 | 2022 | 352 | 0.660 |
Why?
|
Ultrasonography, Doppler | 1 | 2020 | 458 | 0.630 |
Why?
|
Mitral Valve Stenosis | 1 | 2020 | 376 | 0.630 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2022 | 686 | 0.620 |
Why?
|
Coronary Aneurysm | 2 | 2018 | 237 | 0.620 |
Why?
|
Intestinal Diseases | 2 | 2022 | 530 | 0.620 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.600 |
Why?
|
Lymphatic Diseases | 3 | 2015 | 324 | 0.600 |
Why?
|
Aortic Aneurysm | 1 | 2022 | 643 | 0.600 |
Why?
|
Coronary Vessel Anomalies | 2 | 2018 | 314 | 0.600 |
Why?
|
Image Enhancement | 3 | 2019 | 2921 | 0.600 |
Why?
|
Veins | 1 | 2021 | 770 | 0.580 |
Why?
|
Plaque, Atherosclerotic | 4 | 2024 | 1519 | 0.580 |
Why?
|
Lymphoma | 3 | 2017 | 1877 | 0.560 |
Why?
|
Pelvis | 4 | 2020 | 730 | 0.550 |
Why?
|
Vascular Malformations | 1 | 2021 | 454 | 0.530 |
Why?
|
Abdominal Neoplasms | 1 | 2017 | 292 | 0.520 |
Why?
|
Radiotherapy, Conformal | 1 | 2018 | 548 | 0.510 |
Why?
|
Heart Transplantation | 3 | 2024 | 3110 | 0.500 |
Why?
|
Urinary Reservoirs, Continent | 1 | 2014 | 29 | 0.480 |
Why?
|
Artifacts | 2 | 2022 | 1904 | 0.480 |
Why?
|
Urogenital Surgical Procedures | 1 | 2014 | 35 | 0.480 |
Why?
|
Urinary Diversion | 1 | 2014 | 138 | 0.460 |
Why?
|
Male Urogenital Diseases | 1 | 2013 | 48 | 0.450 |
Why?
|
Pericardium | 1 | 2018 | 667 | 0.450 |
Why?
|
Adipose Tissue | 2 | 2018 | 3279 | 0.450 |
Why?
|
Lymph Nodes | 6 | 2020 | 3474 | 0.440 |
Why?
|
Urogenital Neoplasms | 1 | 2014 | 137 | 0.430 |
Why?
|
Testicular Neoplasms | 3 | 2015 | 804 | 0.430 |
Why?
|
Infectious Mononucleosis | 1 | 2013 | 131 | 0.430 |
Why?
|
Viscera | 1 | 2013 | 139 | 0.420 |
Why?
|
Mitral Valve | 1 | 2020 | 1491 | 0.410 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2017 | 546 | 0.410 |
Why?
|
Kidney Function Tests | 1 | 2014 | 684 | 0.410 |
Why?
|
Digestive System Diseases | 1 | 2013 | 147 | 0.410 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2015 | 3327 | 0.400 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2018 | 2737 | 0.390 |
Why?
|
Penile Neoplasms | 1 | 2012 | 160 | 0.390 |
Why?
|
Prostatic Neoplasms | 5 | 2020 | 11124 | 0.380 |
Why?
|
Mitral Valve Insufficiency | 1 | 2020 | 1422 | 0.370 |
Why?
|
Thrombosis | 2 | 2021 | 2968 | 0.360 |
Why?
|
Occupational Exposure | 1 | 2020 | 1796 | 0.360 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2024 | 290 | 0.350 |
Why?
|
Coronary Artery Disease | 5 | 2024 | 6487 | 0.350 |
Why?
|
Pancreatic Neoplasms | 6 | 2022 | 5256 | 0.350 |
Why?
|
Androgen Antagonists | 1 | 2018 | 1377 | 0.350 |
Why?
|
Radiology | 1 | 2024 | 2100 | 0.350 |
Why?
|
Humans | 88 | 2024 | 744343 | 0.350 |
Why?
|
Arrhythmias, Cardiac | 1 | 2019 | 2268 | 0.340 |
Why?
|
Internship and Residency | 2 | 2022 | 5788 | 0.320 |
Why?
|
Inflammation | 5 | 2024 | 10638 | 0.320 |
Why?
|
Diffusion Tensor Imaging | 1 | 2018 | 2305 | 0.310 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1671 | 0.310 |
Why?
|
Urinary Bladder | 1 | 2014 | 1172 | 0.300 |
Why?
|
Immunoglobulin G | 2 | 2024 | 4560 | 0.300 |
Why?
|
Heart Ventricles | 1 | 2019 | 3821 | 0.290 |
Why?
|
Societies, Medical | 7 | 2023 | 3743 | 0.290 |
Why?
|
Health Personnel | 1 | 2020 | 3218 | 0.290 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2013 | 570 | 0.280 |
Why?
|
Prostate | 1 | 2014 | 1774 | 0.270 |
Why?
|
Male | 48 | 2024 | 350118 | 0.270 |
Why?
|
Blood Coagulation Disorders | 2 | 2021 | 337 | 0.270 |
Why?
|
Collagen | 1 | 2014 | 2689 | 0.260 |
Why?
|
Coronary Stenosis | 2 | 2023 | 834 | 0.250 |
Why?
|
Positron-Emission Tomography | 3 | 2019 | 6234 | 0.250 |
Why?
|
Heart | 2 | 2018 | 4467 | 0.250 |
Why?
|
Coronary Vessels | 4 | 2022 | 3107 | 0.240 |
Why?
|
Gastrointestinal Diseases | 1 | 2013 | 1170 | 0.240 |
Why?
|
Tuberous Sclerosis | 3 | 2022 | 1029 | 0.230 |
Why?
|
Middle Aged | 36 | 2024 | 213383 | 0.230 |
Why?
|
Algorithms | 2 | 2022 | 13881 | 0.230 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2023 | 45 | 0.220 |
Why?
|
Aged | 29 | 2023 | 163280 | 0.220 |
Why?
|
Lymphatic Metastasis | 7 | 2020 | 2924 | 0.220 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15165 | 0.220 |
Why?
|
Sensitivity and Specificity | 8 | 2019 | 14722 | 0.220 |
Why?
|
Diagnostic Errors | 2 | 2024 | 1257 | 0.210 |
Why?
|
Peripheral Arterial Disease | 2 | 2023 | 1188 | 0.210 |
Why?
|
Angiomyolipoma | 2 | 2015 | 190 | 0.210 |
Why?
|
Phlebography | 1 | 2023 | 333 | 0.210 |
Why?
|
Neuroendocrine Tumors | 2 | 2022 | 594 | 0.200 |
Why?
|
Cardiac-Gated Imaging Techniques | 2 | 2019 | 143 | 0.200 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2133 | 0.200 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2022 | 140 | 0.200 |
Why?
|
Diagnosis, Differential | 8 | 2021 | 12959 | 0.190 |
Why?
|
Carcinoma, Renal Cell | 2 | 2015 | 3143 | 0.190 |
Why?
|
Abdomen | 2 | 2019 | 1118 | 0.190 |
Why?
|
Retrospective Studies | 22 | 2023 | 77449 | 0.190 |
Why?
|
Aneurysm, False | 1 | 2023 | 276 | 0.190 |
Why?
|
Predictive Value of Tests | 14 | 2023 | 15076 | 0.180 |
Why?
|
Upper Extremity Deep Vein Thrombosis | 1 | 2020 | 26 | 0.180 |
Why?
|
Diverticulum | 1 | 2021 | 136 | 0.180 |
Why?
|
Biopsy, Needle | 2 | 2018 | 1641 | 0.180 |
Why?
|
Kidney Neoplasms | 3 | 2015 | 4262 | 0.180 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2012 | 2245 | 0.180 |
Why?
|
Female | 37 | 2024 | 380194 | 0.170 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2019 | 2016 | 0.170 |
Why?
|
Adenocarcinoma | 2 | 2014 | 6364 | 0.170 |
Why?
|
Epigastric Arteries | 2 | 2022 | 96 | 0.170 |
Why?
|
Quinolines | 1 | 2024 | 732 | 0.170 |
Why?
|
Echocardiography | 3 | 2023 | 5102 | 0.160 |
Why?
|
Kidney | 1 | 2014 | 7186 | 0.160 |
Why?
|
Nitroglycerin | 1 | 2019 | 325 | 0.160 |
Why?
|
Platelet Count | 1 | 2020 | 781 | 0.150 |
Why?
|
Necrosis | 1 | 2022 | 1643 | 0.150 |
Why?
|
Aortic Diseases | 1 | 2024 | 742 | 0.150 |
Why?
|
Extremities | 1 | 2023 | 865 | 0.150 |
Why?
|
Vasculitis | 1 | 2021 | 519 | 0.150 |
Why?
|
Appendiceal Neoplasms | 1 | 2019 | 146 | 0.150 |
Why?
|
Atrial Appendage | 1 | 2021 | 283 | 0.150 |
Why?
|
Adult | 22 | 2021 | 214055 | 0.140 |
Why?
|
Ischemia | 2 | 2023 | 1907 | 0.140 |
Why?
|
Statistics as Topic | 2 | 2014 | 2373 | 0.140 |
Why?
|
Iopamidol | 2 | 2016 | 191 | 0.140 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2017 | 168 | 0.140 |
Why?
|
Cardiovascular System | 1 | 2023 | 832 | 0.130 |
Why?
|
Evidence-Based Medicine | 3 | 2022 | 3610 | 0.130 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2017 | 153 | 0.130 |
Why?
|
Heart Valve Diseases | 1 | 2023 | 1073 | 0.130 |
Why?
|
Hemoptysis | 1 | 2016 | 155 | 0.130 |
Why?
|
Reproducibility of Results | 6 | 2019 | 19905 | 0.130 |
Why?
|
alpha-Fetoproteins | 1 | 2015 | 224 | 0.130 |
Why?
|
Upper Extremity | 2 | 2020 | 648 | 0.130 |
Why?
|
Incidental Findings | 2 | 2017 | 689 | 0.130 |
Why?
|
Vasodilation | 1 | 2019 | 944 | 0.130 |
Why?
|
Blood Coagulation | 1 | 2021 | 1127 | 0.130 |
Why?
|
Hospitals, General | 2 | 2016 | 749 | 0.130 |
Why?
|
Vasodilator Agents | 1 | 2019 | 977 | 0.120 |
Why?
|
Foreign-Body Migration | 1 | 2016 | 222 | 0.120 |
Why?
|
Acute Coronary Syndrome | 2 | 2018 | 2337 | 0.120 |
Why?
|
Clinical Protocols | 1 | 2020 | 1462 | 0.120 |
Why?
|
Pulmonary Embolism | 2 | 2020 | 2376 | 0.120 |
Why?
|
Mammaplasty | 2 | 2022 | 1204 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2017 | 266 | 0.120 |
Why?
|
Ganglia, Sympathetic | 1 | 2014 | 62 | 0.120 |
Why?
|
Preoperative Care | 2 | 2014 | 2250 | 0.120 |
Why?
|
Metal Nanoparticles | 1 | 2018 | 405 | 0.120 |
Why?
|
Treatment Outcome | 9 | 2023 | 63114 | 0.120 |
Why?
|
Pancreaticoduodenectomy | 1 | 2017 | 503 | 0.120 |
Why?
|
Metabolic Clearance Rate | 1 | 2014 | 380 | 0.120 |
Why?
|
Sarcoidosis | 1 | 2019 | 506 | 0.120 |
Why?
|
Calcium | 2 | 2023 | 5756 | 0.110 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7279 | 0.110 |
Why?
|
Lymphomatoid Granulomatosis | 1 | 2013 | 16 | 0.110 |
Why?
|
Substance Abuse, Intravenous | 1 | 2018 | 525 | 0.110 |
Why?
|
Abdominal Wall | 1 | 2014 | 157 | 0.110 |
Why?
|
Radiography | 1 | 2024 | 7023 | 0.110 |
Why?
|
Embolism, Paradoxical | 1 | 2012 | 58 | 0.110 |
Why?
|
Splenomegaly | 1 | 2013 | 190 | 0.110 |
Why?
|
Appendicitis | 1 | 2019 | 645 | 0.110 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 722 | 0.110 |
Why?
|
Embolism, Air | 1 | 2012 | 111 | 0.110 |
Why?
|
Vascular System Injuries | 1 | 2016 | 250 | 0.110 |
Why?
|
Magnetite Nanoparticles | 1 | 2014 | 321 | 0.100 |
Why?
|
Radiation Dosage | 2 | 2018 | 1928 | 0.100 |
Why?
|
Gallbladder Diseases | 1 | 2013 | 125 | 0.100 |
Why?
|
Musculoskeletal Diseases | 1 | 2018 | 581 | 0.100 |
Why?
|
Diverticulitis, Colonic | 1 | 2013 | 128 | 0.100 |
Why?
|
Seminoma | 1 | 2013 | 137 | 0.100 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2021 | 1390 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 2 | 2012 | 2849 | 0.100 |
Why?
|
Surgical Mesh | 1 | 2014 | 276 | 0.100 |
Why?
|
Aged, 80 and over | 10 | 2021 | 57776 | 0.100 |
Why?
|
Intracranial Embolism | 1 | 2012 | 202 | 0.100 |
Why?
|
Hepatitis | 1 | 2013 | 227 | 0.100 |
Why?
|
Arteries | 1 | 2016 | 1119 | 0.090 |
Why?
|
Intermittent Claudication | 2 | 2023 | 309 | 0.090 |
Why?
|
Pacemaker, Artificial | 1 | 2016 | 816 | 0.090 |
Why?
|
Adrenal Glands | 1 | 2013 | 546 | 0.090 |
Why?
|
Radiopharmaceuticals | 3 | 2019 | 2645 | 0.090 |
Why?
|
Peritoneal Neoplasms | 1 | 2016 | 665 | 0.090 |
Why?
|
Myocarditis | 1 | 2018 | 771 | 0.090 |
Why?
|
Cardiovascular Agents | 1 | 2017 | 850 | 0.090 |
Why?
|
Stomach | 1 | 2015 | 697 | 0.090 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2015 | 501 | 0.090 |
Why?
|
Registries | 4 | 2018 | 8089 | 0.090 |
Why?
|
Constriction, Pathologic | 2 | 2024 | 1107 | 0.090 |
Why?
|
Emergency Service, Hospital | 3 | 2018 | 7659 | 0.090 |
Why?
|
Tissue Distribution | 1 | 2014 | 2327 | 0.090 |
Why?
|
Foramen Ovale, Patent | 1 | 2012 | 223 | 0.090 |
Why?
|
Vena Cava Filters | 1 | 2012 | 252 | 0.090 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2569 | 0.090 |
Why?
|
Radiography, Abdominal | 1 | 2013 | 537 | 0.090 |
Why?
|
Tachycardia, Ventricular | 1 | 2018 | 1273 | 0.090 |
Why?
|
Inpatients | 1 | 2021 | 2518 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3255 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3778 | 0.080 |
Why?
|
Sex Factors | 2 | 2020 | 10397 | 0.080 |
Why?
|
Pancreas | 1 | 2015 | 1686 | 0.080 |
Why?
|
Endovascular Procedures | 1 | 2021 | 1979 | 0.080 |
Why?
|
Prosthesis Implantation | 1 | 2012 | 642 | 0.080 |
Why?
|
Ultrasonography | 1 | 2021 | 5985 | 0.080 |
Why?
|
Gadolinium DTPA | 3 | 2016 | 836 | 0.080 |
Why?
|
Length of Stay | 1 | 2020 | 6309 | 0.070 |
Why?
|
Cardiomyopathies | 1 | 2019 | 1912 | 0.070 |
Why?
|
Cerebral Angiography | 1 | 2012 | 1285 | 0.070 |
Why?
|
HIV Infections | 2 | 2024 | 16718 | 0.070 |
Why?
|
Adolescent | 8 | 2022 | 85781 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2022 | 3445 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8642 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2017 | 1634 | 0.070 |
Why?
|
Prospective Studies | 5 | 2023 | 53288 | 0.070 |
Why?
|
Kidney Diseases | 1 | 2016 | 2149 | 0.060 |
Why?
|
Colonoscopy | 1 | 2013 | 1367 | 0.060 |
Why?
|
Myocardium | 1 | 2018 | 4776 | 0.060 |
Why?
|
Neoplasm Staging | 5 | 2020 | 11031 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11366 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2021 | 4584 | 0.060 |
Why?
|
Young Adult | 7 | 2016 | 56430 | 0.060 |
Why?
|
Hemorrhage | 1 | 2016 | 3461 | 0.060 |
Why?
|
Radiography, Interventional | 1 | 2012 | 1095 | 0.060 |
Why?
|
Pilot Projects | 2 | 2015 | 8324 | 0.060 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3616 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 2013 | 1206 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4149 | 0.060 |
Why?
|
Neoplasms, Second Primary | 1 | 2012 | 1061 | 0.060 |
Why?
|
Ultrasonography, Interventional | 1 | 2012 | 1486 | 0.060 |
Why?
|
Societies, Scientific | 1 | 2023 | 220 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11727 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2021 | 5034 | 0.050 |
Why?
|
Boston | 4 | 2016 | 9313 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2024 | 15295 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2022 | 20822 | 0.050 |
Why?
|
United States | 7 | 2023 | 69872 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2018 | 8949 | 0.050 |
Why?
|
Risk Factors | 4 | 2023 | 72290 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2541 | 0.050 |
Why?
|
Limb Salvage | 1 | 2023 | 433 | 0.050 |
Why?
|
Tuberculosis | 1 | 2014 | 1912 | 0.050 |
Why?
|
Subclavian Artery | 1 | 2021 | 130 | 0.050 |
Why?
|
Lipoproteins, LDL | 1 | 2024 | 640 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2018 | 21746 | 0.050 |
Why?
|
Computer Simulation | 1 | 2014 | 6196 | 0.050 |
Why?
|
Tricuspid Valve | 1 | 2023 | 403 | 0.050 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2015 | 3336 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4838 | 0.040 |
Why?
|
Administration, Sublingual | 1 | 2019 | 56 | 0.040 |
Why?
|
Device Removal | 2 | 2016 | 656 | 0.040 |
Why?
|
Transdermal Patch | 1 | 2019 | 51 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15540 | 0.040 |
Why?
|
Tablets | 1 | 2019 | 145 | 0.040 |
Why?
|
Prevalence | 4 | 2018 | 15226 | 0.040 |
Why?
|
Giant Cells | 1 | 2018 | 187 | 0.040 |
Why?
|
Models, Biological | 1 | 2014 | 9583 | 0.040 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2018 | 364 | 0.040 |
Why?
|
Ventricular Dysfunction | 1 | 2018 | 143 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 2019 | 711 | 0.040 |
Why?
|
Angiography | 1 | 2022 | 1639 | 0.040 |
Why?
|
Reference Values | 2 | 2015 | 4982 | 0.040 |
Why?
|
Aerosols | 1 | 2019 | 625 | 0.040 |
Why?
|
Equipment Design | 2 | 2016 | 3582 | 0.030 |
Why?
|
ROC Curve | 2 | 2015 | 3527 | 0.030 |
Why?
|
Acute Disease | 2 | 2019 | 7149 | 0.030 |
Why?
|
HIV | 1 | 2022 | 1604 | 0.030 |
Why?
|
Electrocardiography | 2 | 2019 | 6442 | 0.030 |
Why?
|
Aorta, Thoracic | 1 | 2021 | 1082 | 0.030 |
Why?
|
Infant | 1 | 2017 | 35136 | 0.030 |
Why?
|
Aortography | 1 | 2016 | 437 | 0.030 |
Why?
|
Lower Extremity | 1 | 2022 | 1158 | 0.030 |
Why?
|
Echocardiography, Transesophageal | 1 | 2021 | 1133 | 0.030 |
Why?
|
Iodine | 1 | 2016 | 286 | 0.030 |
Why?
|
CA-125 Antigen | 1 | 2016 | 286 | 0.030 |
Why?
|
Phenotype | 1 | 2012 | 16365 | 0.030 |
Why?
|
Mastectomy | 1 | 2022 | 1793 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 2959 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2759 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 2016 | 665 | 0.030 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1184 | 0.030 |
Why?
|
Gadolinium | 1 | 2016 | 952 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8388 | 0.020 |
Why?
|
Massachusetts | 2 | 2016 | 8663 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2012 | 1420 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12026 | 0.020 |
Why?
|
Causality | 1 | 2016 | 1275 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13102 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2902 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9146 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 2018 | 1440 | 0.020 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 884 | 0.020 |
Why?
|
Macrophages | 1 | 2022 | 5655 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 21683 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5078 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8340 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2012 | 2110 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3508 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39050 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10252 | 0.020 |
Why?
|
Risk Assessment | 2 | 2018 | 23338 | 0.010 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2013 | 1624 | 0.010 |
Why?
|
Incidence | 2 | 2012 | 20947 | 0.010 |
Why?
|
Germ-Line Mutation | 1 | 2011 | 1788 | 0.010 |
Why?
|
Time Factors | 2 | 2016 | 40075 | 0.010 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2016 | 2208 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2013 | 2728 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12788 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10388 | 0.010 |
Why?
|
Regression Analysis | 1 | 2012 | 6459 | 0.010 |
Why?
|
Child | 3 | 2015 | 77709 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13284 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 12951 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2012 | 13989 | 0.010 |
Why?
|
Liver | 1 | 2012 | 7474 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29063 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 9239 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18370 | 0.010 |
Why?
|
Cohort Studies | 1 | 2015 | 40561 | 0.010 |
Why?
|
Animals | 1 | 2024 | 168757 | 0.010 |
Why?
|
Mutation | 1 | 2012 | 29786 | 0.000 |
Why?
|